Get the Stockscreener App
101.64
1.44%
-1.48
After Hours:
101.64
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Merck Co Inc stock is traded at $101.64, with a volume of 5.57M.
It is down -1.44% in the last 24 hours and down -2.01% over the past month.
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.
See More
Previous Close:
$103.12
Open:
$102.875
24h Volume:
5.57M
Relative Volume:
0.58
Market Cap:
$257.11B
Revenue:
$63.17B
Net Income/Loss:
$12.15B
P/E Ratio:
56.47
EPS:
1.8
Net Cash Flow:
$14.84B
1W Performance:
+2.48%
1M Performance:
-2.01%
6M Performance:
-19.27%
1Y Performance:
+0.50%
1-Day Range:
$101.53
$103.04
1-Week Range:
$99.51
$103.45
52-Week Range:
$94.48
$134.63
Merck Co Inc Stock (MRK) Company Profile
Name
Merck Co Inc
Sector
Industry
Phone
908-740-4000
Address
2000 GALLOPING HILL ROAD, KENILWORTH, NJ
Compare MRK with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MRK
Merck Co Inc
|
101.64 | 257.11B | 63.17B | 12.15B | 14.84B | 4.77 |
|
LLY
Lilly Eli Co
|
795.35 | 755.90B | 40.86B | 8.37B | -2.28B | 9.25 |
|
NVO
Novo Nordisk Adr
|
106.80 | 474.49B | 39.36B | 13.79B | 9.83B | 3.086 |
|
JNJ
Johnson Johnson
|
155.01 | 353.35B | 87.70B | 14.68B | 19.03B | 6.05 |
|
ABBV
Abbvie Inc
|
182.93 | 323.26B | 55.53B | 5.12B | 15.62B | 2.88 |
Merck Co Inc Stock (MRK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-15-24 | Initiated | Wolfe Research | Peer Perform |
| Nov-11-24 | Downgrade | Daiwa Securities | Buy → Neutral |
| Oct-17-24 | Initiated | Bernstein | Mkt Perform |
| Mar-11-24 | Downgrade | Societe Generale | Hold → Sell |
| Jan-04-24 | Upgrade | TD Cowen | Market Perform → Outperform |
| Nov-09-23 | Initiated | Deutsche Bank | Buy |
| Oct-27-23 | Upgrade | BMO Capital Markets | Market Perform → Outperform |
| Oct-20-23 | Upgrade | UBS | Neutral → Buy |
| Jul-14-23 | Initiated | HSBC Securities | Hold |
| Apr-13-23 | Upgrade | Citigroup | Neutral → Buy |
| Mar-28-23 | Downgrade | Societe Generale | Buy → Hold |
| Mar-13-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Mar-06-23 | Initiated | Jefferies | Buy |
| Feb-22-23 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Jan-04-23 | Upgrade | BofA Securities | Neutral → Buy |
| Nov-18-22 | Initiated | Credit Suisse | Outperform |
| Oct-10-22 | Upgrade | Guggenheim | Neutral → Buy |
| Sep-14-22 | Upgrade | Berenberg | Hold → Buy |
| Jul-06-22 | Upgrade | Daiwa Securities | Neutral → Buy |
| Jun-06-22 | Resumed | SVB Leerink | Outperform |
| Apr-06-22 | Resumed | Morgan Stanley | Equal-Weight |
| Dec-17-21 | Initiated | Goldman | Buy |
| Dec-16-21 | Initiated | Daiwa Securities | Neutral |
| Dec-13-21 | Downgrade | UBS | Buy → Neutral |
| Dec-09-21 | Initiated | Wells Fargo | Overweight |
| Dec-07-21 | Downgrade | Guggenheim | Buy → Neutral |
| Nov-29-21 | Downgrade | Citigroup | Buy → Neutral |
| Nov-19-21 | Initiated | BMO Capital Markets | Market Perform |
| Nov-01-21 | Upgrade | Argus | Hold → Buy |
| Sep-07-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jul-27-21 | Resumed | Truist | Buy |
| May-20-21 | Downgrade | Argus | Buy → Hold |
| Apr-07-21 | Resumed | RBC Capital Mkts | Sector Perform |
| Nov-10-20 | Resumed | Bernstein | Outperform |
| Sep-29-20 | Initiated | Berenberg | Hold |
| Aug-03-20 | Upgrade | Goldman | Neutral → Buy |
| Jun-12-20 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Feb-27-20 | Initiated | Barclays | Overweight |
| Jan-07-20 | Initiated | RBC Capital Mkts | Sector Perform |
| Oct-17-19 | Resumed | BofA/Merrill | Neutral |
| Aug-16-19 | Initiated | SVB Leerink | Outperform |
| Jul-03-19 | Initiated | Mizuho | Buy |
| May-28-19 | Initiated | Goldman | Neutral |
| May-13-19 | Upgrade | Atlantic Equities | Neutral → Overweight |
| Oct-16-18 | Reiterated | Citigroup | Buy |
| Oct-09-18 | Resumed | Guggenheim | Buy |
| Apr-23-18 | Upgrade | Goldman | Neutral → Buy |
| Apr-17-18 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Apr-05-18 | Upgrade | Barclays | Equal Weight → Overweight |
| Mar-12-18 | Upgrade | Leerink Partners | Mkt Perform → Outperform |
| Feb-14-18 | Reiterated | Leerink Partners | Mkt Perform |
| Feb-07-18 | Reiterated | Morgan Stanley | Equal-Weight |
| Jan-16-18 | Upgrade | SunTrust | Hold → Buy |
View All
Merck Co Inc Stock (MRK) Latest News
BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp Reduces Stock Holdings in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Shares Sold by PFM Health Sciences LP - MarketBeat
Caisse DE Depot ET Placement DU Quebec Purchases 2,194,463 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Trading Down 1.1%What's Next? - MarketBeat
Captrust Financial Advisors Acquires 34,715 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Rockefeller Capital Management L.P. Sells 43,500 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Infrastructure Capital Advisors LLC Purchases New Stake in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Martingale Asset Management L P Has $39.98 Million Position in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Hantz Financial Services Inc. Sells 6,731 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Blood Culture Tests Market is Slated to Evolve at an Impressive 12.3% CAGR through 2031 | SkyQuest Technology - Benzinga
Merck & Co., Inc. (NYSE:MRK) Trading 1.5% HigherHere's What Happened - MarketBeat
Vinva Investment Management Ltd Boosts Position in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Position Boosted by Financial Counselors Inc. - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Shares Acquired by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - MarketBeat
Noesis Capital Mangement Corp Purchases 11,031 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Shares Purchased by CreativeOne Wealth LLC - MarketBeat
DRW Securities LLC Has $300,000 Stock Holdings in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Stock Price Up 1.5%What's Next? - MarketBeat
FORA Capital LLC Purchases New Stake in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
MetLife Investment Management LLC Sells 18,630 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
BNP Paribas Has $36.39 Million Stake in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Shares Purchased by Healthcare of Ontario Pension Plan Trust Fund - MarketBeat
Bridgewater Associates LP Sells 247,721 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Glenmede Trust Co. NA Has $124.72 Million Stock Holdings in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Townsquare Capital LLC Acquires 9,305 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Loomis Sayles & Co. L P Raises Position in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck & Co. Inc. stock rises Tuesday, still underperforms market - MarketWatch
Merck & Co., Inc. (NYSE:MRK) Trading Down 1.3%What's Next? - MarketBeat
Thematics Asset Management Raises Holdings in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Shum Financial Group Inc. Purchases New Shares in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Holdings Lowered by Lazard Freres Gestion S.A.S. - MarketBeat
Merck & Co. (MRK) Fell As It Faced Some Demand Headwinds In China - Insider Monkey
Merck & Co., Inc. (NYSE:MRK) Shares Bought by D.A. Davidson & CO. - MarketBeat
Fmr LLC Sells 946,950 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
The Manufacturers Life Insurance Company Has $585.07 Million Stock Holdings in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck CEO to Present at Citi Global Healthcare Conference 2024 | MRK Stock News - StockTitan
Merck & Co., Inc. (NYSE:MRK) Trading 1.4% HigherWhat's Next? - MarketBeat
Merck & Co. Inc. stock outperforms competitors on strong trading day - MarketWatch
Merck & Co., Inc. (MRK) Announces New Board Appointment and By-Law Amendments - GuruFocus.com
Why Is Merck Stock Trading Higher On Monday? - Benzinga
Merck & Co., Inc. (NYSE:MRK) Shares Acquired by Qsemble Capital Management LP - MarketBeat
Private Trust Co. NA Lowers Position in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Horizon Kinetics Asset Management LLC Raises Position in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Mirabella Financial Services LLP Buys New Position in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck: successful study in arterial hypertension - Marketscreener.com
Davis R M Inc. Reduces Stock Holdings in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Position Lessened by Douglass Winthrop Advisors LLC - MarketBeat
Fisher Asset Management LLC Increases Stock Holdings in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck's therapy for rare lung condition shown to help reduce risk of death in study - Reuters
Merck Announces Pivotal Phase 3 Zenith Trial Evaluating Winrevair Met Primary Endpoint At Interim Analysis - Marketscreener.com
Merck Co Inc Stock (MRK) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.86%
0.08%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):